DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $13,272,000 | +23.6% | 40,340 | +14.4% | 1.15% | +20.7% |
| Q3 2021 | $10,737,000 | -52.6% | 35,268 | -58.2% | 0.95% | -46.1% |
| Q2 2021 | $22,633,000 | -13.9% | 84,338 | -27.8% | 1.77% | -21.2% |
| Q1 2021 | $26,279,000 | -33.0% | 116,752 | -33.9% | 2.24% | -51.1% |
| Q4 2020 | $39,241,000 | -29.0% | 176,652 | -31.2% | 4.59% | -17.4% |
| Q3 2020 | $55,286,000 | +64.6% | 256,752 | +35.1% | 5.56% | +73.8% |
| Q2 2020 | $33,594,000 | +21.3% | 189,978 | -5.1% | 3.20% | -16.5% |
| Q1 2020 | $27,696,000 | -55.2% | 200,104 | -50.3% | 3.83% | -46.1% |
| Q4 2019 | $61,855,000 | +118.4% | 403,014 | +105.5% | 7.10% | +186.2% |
| Q3 2019 | $28,320,000 | -4.4% | 196,084 | -5.4% | 2.48% | +25.3% |
| Q2 2019 | $29,622,000 | -5.4% | 207,261 | -12.6% | 1.98% | -18.8% |
| Q1 2019 | $31,318,000 | +487.7% | 237,221 | +359.0% | 2.44% | +440.4% |
| Q4 2018 | $5,329,000 | -81.5% | 51,681 | -80.5% | 0.45% | -69.0% |
| Q3 2018 | $28,775,000 | +154.0% | 264,821 | +130.7% | 1.45% | +53.4% |
| Q2 2018 | $11,329,000 | +42.2% | 114,810 | +41.1% | 0.95% | -2.7% |
| Q1 2018 | $7,969,000 | -44.0% | 81,390 | -57.1% | 0.97% | +94.2% |
| Q1 2014 | $14,243,000 | -2.6% | 189,900 | +0.2% | 0.50% | +5.7% |
| Q4 2013 | $14,629,000 | -23.0% | 189,500 | -36.8% | 0.47% | -33.5% |
| Q2 2013 | $18,990,000 | – | 300,000 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |